AI Verdict
PVLA has stronger fundamentals based on our AI analysis.
PVLA vs PUBM Fundamental Comparison
| Metric | PVLA | PUBM |
|---|---|---|
| Revenue | $2.6M | $282.9M |
| Net Income | $-41.7M | $-14.5M |
| Net Margin | -1,610.6% | -5.1% |
| ROE | -149.1% | -5.5% |
| ROA | -70.0% | -2.1% |
| Current Ratio | 5.20x | 1.39x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-3.71 | $-0.31 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PVLA vs PUBM: Frequently Asked Questions
Is PVLA or PUBM a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PVLA has stronger fundamentals. PVLA is rated HOLD (78% confidence) while PUBM is rated HOLD (72% confidence). This is not investment advice.
How does PVLA compare to PUBM fundamentally?
PALVELLA THERAPEUTICS, INC. has ROE of -149.1% vs PubMatic, Inc.'s -5.5%. Net margins are -1,610.6% vs -5.1% respectively.
Which stock pays higher dividends, PVLA or PUBM?
PVLA has a dividend yield of N/A or no dividend while PUBM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PVLA or PUBM for long term?
For long-term investing, consider that PVLA has HOLD rating with 78% confidence, while PUBM has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PVLA vs PUBM?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PVLA vs PUBM, the AI consensus favors PVLA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.